Table 6 Univariate analysis of factors possibly associated with a poor functional outcome in septic arthritis
From: Morbimortality in adult patients with septic arthritis: a three-year hospital-based study
Yes (N = 28) | No (N = 60) | p-value | Odds ratio [95 % CI] | Univariate analysis p-value | |
|---|---|---|---|---|---|
Age (years) | 64.0 [36–90] | 54.5 [16–95] | 0.076 | 1.02 [1.001–1.05] | 0.049 |
Gender (Female) | 10 (36 %) | 19 (32 %) | 0.707 | 1.20 [0.46–3.07] | 0.707 |
Knee involvement | 3 (11 %) | 13 (22 %) | 0.252 | 0.43 [0.09–1.50] | 0.224 |
Hip involvement | 8 (29 %) | 2 (3 %) | 0.001 | 11.60 [2.65–81.29] | 0.003 |
Multiple joint involvement | 3 (11 %) | 4 (7 %) | 0.675 | 1.68 [0.31–8.17] | 0.517 |
Small joint involvement | 7 (25 %) | 23 (38 %) | 0.219 | 0.54 [0.19–1.41] | 0.223 |
Cardiovascular disease | 12 (43 %) | 19 (32 %) | 0.306 | 1.62 [0.64–4.10] | 0.308 |
Skin involvement | 7 (25 %) | 3 (5 %) | 0.010 | 6.33 [1.60–31.55] | 0.012 |
Rheumatoid arthritis and related conditions | 1 (4 %) | 3 (5 %) | 1 | 0.70 [0.03–5.79] | 0.765 |
Previous cancer | 8 (29 %) | 7 (12 %) | 0.049 | 3.03 [0.97–9.73] | 0.056 |
Diabetes mellitus | 7 (25 %) | 13 (22 %) | 0.728 | 1.21 [0.40–3.40] | 0.728 |
Time to presentation (days) | 15 [0–105] | 5 [0–91] | 0.016 | 1.02 [1.002–1.04] | 0.034 |
Creatinine clearance (MDRD, ml/min) | 71 [5–130] | 94 [29–150] | 0.019 | 0.98 [0.97–0.99] | 0.013 |
C-reactive protein (mg/l) | 120 [3–342] | 105.5 [3–465] | 0.862 | 0.999 [0.995–1.004] | 0.839 |
Staphylococcus aureus | 15 (58 %) | 29 (55 %) | 0.802 | 1.13 [0.44–2.96] | 0.803 |
Joint surgery | 17 (61 %) | 33 (55 %) | 0.614 | 1.26 [0.51–3.21] | 0.615 |